ACM
Asymmetry Capital Management Portfolio holdings
AUM
$188M
This Quarter Return
+9.67%
1 Year Return
+45.88%
3 Year Return
+300.28%
5 Year Return
+633.15%
10 Year Return
–
AUM
$193M
AUM Growth
+$193M
(-12%)
Cap. Flow
-$21.3M
Cap. Flow
% of AUM
-11%
Top 10 Holdings %
Top 10 Hldgs %
57.01%
Holding
46
New
13
Increased
3
Reduced
13
Closed
17
Top Buys
| 1 |
Sotera Health
SHC
|
$11.7M |
| 2 |
Adaptive Biotechnologies
ADPT
|
$11.6M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
$11.6M |
| 4 |
UnitedHealth
UNH
|
$10.9M |
| 5 |
AstraZeneca
AZN
|
$10.9M |
Top Sells
| 1 |
Viatris
VTRS
|
$21.2M |
| 2 |
Standard BioTools
LAB
|
$9.27M |
| 3 |
BioMarin Pharmaceuticals
BMRN
|
$7.73M |
| 4 |
SAGE
Sage Therapeutics
SAGE
|
$7.63M |
| 5 |
Codexis
CDXS
|
$6.95M |
Sector Composition
| 1 | Healthcare | 99.55% |
| 2 | Financials | 0.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Jazz Pharmaceuticals
JAZZ
$7.75B
| $12.2M | 6.31% | 74,164 -15,725 | -17% | -$2.58M |
|
|
2
Sotera Health
SHC
$4.65B
| $11.7M | 6.03% | +467,277 | New | +$11.7M |
|
|
3
Adaptive Biotechnologies
ADPT
$2.01B
| $11.6M | 5.99% | +287,490 | New | +$11.6M |
|
|
4
Vertex Pharmaceuticals
VRTX
$100B
| $11.6M | 5.99% | +53,855 | New | +$11.6M |
|
|
ARNA
5
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $11.3M | 5.86% | 163,135 +61,890 | +61% | +$4.29M |
|
6
Insulet
PODD
$23.9B
| $11.3M | 5.83% | 43,183 -2,441 | -5% | -$637K |
|
|
7
UnitedHealth
UNH
$281B
| $10.9M | 5.65% | +29,357 | New | +$10.9M |
|
|
8
AstraZeneca
AZN
$248B
| $10.9M | 5.63% | +218,918 | New | +$10.9M |
|
9
Guardant Health
GH
$8.41B
| $9.45M | 4.89% | 61,909 -17,330 | -22% | -$2.65M |
|
|
NSTG
10
DELISTED
NanoString Technologies, Inc.
NSTG
| $9.37M | 4.85% | 142,530 -30,332 | -18% | -$1.99M |
|
11
Biodesix
BDSX
$62.6M
| $9.02M | 4.67% | 444,051 -34,934 | -7% | -$710K |
|
12
ESSA Pharma
EPIX
$11.4M
| $8.26M | 4.27% | +284,459 | New | +$8.26M |
|
13
Kura Oncology
KURA
$686M
| $7.84M | 4.06% | 277,468 -69,050 | -20% | -$1.95M |
|
14
Arcus Biosciences
RCUS
$1.13B
| $6.64M | 3.44% | 236,494 -111,914 | -32% | -$3.14M |
|
|
AVDL
15
Avadel Pharmaceuticals
AVDL
$1.43B
| $6.44M | 3.33% | 712,371 -243,485 | -25% | -$2.2M |
|
|
SAGE
16
DELISTED
Sage Therapeutics
SAGE
| $5.96M | 3.08% | 79,650 -102,000 | -56% | -$7.63M |
|
|
JNCE
17
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $5.35M | 2.77% | +520,858 | New | +$5.35M |
|
|
ASLN
18
DELISTED
ASLAN Pharmaceuticals Limited American Depositary Shares
ASLN
| $4.53M | 2.34% | +1,352,577 | New | +$4.53M |
|
|
MRTX
19
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $4.16M | 2.15% | +24,263 | New | +$4.16M |
|
|
RNLX
20
DELISTED
Renalytix plc American Depositary Shares
RNLX
| $4.13M | 2.14% | +160,969 | New | +$4.13M |
|
21
PMV Pharmaceuticals
PMVP
$74.2M
| $3.89M | 2.01% | 118,128 +21,533 | +22% | +$708K |
|
|
MREO
22
Mereo BioPharma
MREO
$272M
| $3.58M | 1.85% | 1,063,264 +323,452 | +44% | +$1.09M |
|
23
iTeos Therapeutics
ITOS
$449M
| $3.5M | 1.81% | 102,286 -36,098 | -26% | -$1.23M |
|
|
RGLS
24
DELISTED
Regulus Therapeutics
RGLS
| $3.1M | 1.6% | +1,985,472 | New | +$3.1M |
|
|
SEEL
25
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
| $2.2M | 1.14% | +440,745 | New | +$2.2M |
|